Zuvexitil 500 Tablet contains Cefuroxime 500 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exerting a bactericidal effect. It is indicated for the treatment of respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, septicemia, bone and joint infections, and uncomplicated gonorrhea. Zuvexitil 500 is also utilized in the management of Lyme disease and surgical prophylaxis to prevent postoperative infections. The tablet formulation ensures convenient oral administration with good bioavailability. Cefuroxime demonstrates activity against both Gram-positive and Gram-negative organisms, including Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Moraxella catarrhalis. Dosage should be individualized based on the severity of infection, renal function, and patient response, typically administered twice daily. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and hypersensitivity reactions. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Zuvexitil 500 Tablet should be used under medical supervision, with adherence to the prescribed course to prevent resistance development.